2927 — AFC-HD AMS Life Science Co Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesBalancedSmall CapTurnaround

Annual income statement for AFC-HD AMS Life Science Co, fiscal year end - August 31st, JPY millions except per share, conversion factor applied.

	2019 August 31st	2020 August 31st	2021 August 31st	C2022 August 31st	2023 August 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	16,253	15,819	22,368	23,025	25,579
Cost of Revenue
Gross Profit	4,521	4,555	6,865	8,583	9,323
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	15,291	14,821	20,126	22,118	24,051
Operating Profit	962	999	2,242	907	1,528
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1,091	1,004	2,158	1,235	1,546
Provision for Income Taxes
Net Income After Taxes	783	677	1,495	738	1,107
Minority Interest
Net Income Before Extraordinary Items
Net Income	783	677	1,496	735	1,103
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	783	677	1,496	735	1,103
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	51.8	52.7	109	67.5	95.4
Dividends per Share
Special Dividends per Share